About the Authors
Mayo Vaccine Research Group, Department of Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, Minnesota, United States of America
Dr. Poland and Dr. Ovsyannikova hold patents for the discovery of novel measles and vaccinia peptides potentially useful in developing new diagnostic assays and vaccines. Dr. Poland provides consultative advice to a number of vaccine companies for novel vaccine development (Novartis, PAXVAX, Emergent, Dynavax, Merck, Avianax, Theraclone, Liquidia, EMD Serano), and serves on a DMSB for Merck for clinical trials of novel vaccines in development. Dr. Kennedy has no competing interests.